Literature DB >> 22382738

The performance of real-time PCR, galactomannan, and fungal culture in the diagnosis of invasive aspergillosis in ventilated patients with chronic obstructive pulmonary disease (COPD).

Valério R Aquino1, Fabiano Nagel, Huander F Andreolla, Fernanda de-Paris, Melissa O Xavier, Luciano Z Goldani, David W Denning, Alessandro C Pasqualotto.   

Abstract

Emerging reports have associated chronic pulmonary obstructive disease (COPD) with invasive aspergillosis (IA), particularly in patients treated with mechanical ventilation and/or corticosteroids. This is a multicentre study in which COPD patients demonstrating a new lung infiltrate while being mechanically ventilated were prospectively evaluated for the presence of IA. From the 47 patients studied, Aspergillus fumigatus was recovered in culture in two patients (4.2%). While serum galactomannan (GM) was negative for 94% of patients, GM levels in respiratory samples were >0.5, >1.0 and >1.5 for 74.5, 40.5, and 21.3% of patients, respectively. PCR was positive for 10 patients in the study but did not differentiate Aspergillus colonization from infection. The combination of PCR and GM in respiratory samples may be an interesting alternative to diagnose IA in COPD patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22382738     DOI: 10.1007/s11046-012-9531-1

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  12 in total

1.  Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.

Authors:  Jorien D'Haese; Koen Theunissen; Edith Vermeulen; Hélène Schoemans; Greet De Vlieger; Liesbet Lammertijn; Philippe Meersseman; Wouter Meersseman; Katrien Lagrou; Johan Maertens
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

2.  A bad bug takes on a new role as a cause of ventilator-associated pneumonia.

Authors:  Elias J Anaissie
Journal:  Am J Respir Crit Care Med       Date:  2008-01-01       Impact factor: 21.405

3.  Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.

Authors:  Alessandro C Pasqualotto; Melissa O Xavier; Letícia B Sánchez; Clarice D A de Oliveira Costa; Sadi M Schio; Spencer M Camargo; Jose J Camargo; Teresa C T Sukiennik; Luiz Carlos Severo
Journal:  Transplantation       Date:  2010-08-15       Impact factor: 4.939

4.  A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.

Authors:  K L Mortensen; H K Johansen; K Fuursted; J D Knudsen; B Gahrn-Hansen; R H Jensen; S J Howard; M C Arendrup
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-04       Impact factor: 3.267

5.  Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease.

Authors:  Florence Ader
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

6.  Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome.

Authors:  J Guinea; M Torres-Narbona; P Gijón; P Muñoz; F Pozo; T Peláez; J de Miguel; E Bouza
Journal:  Clin Microbiol Infect       Date:  2009-11-10       Impact factor: 8.067

7.  Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients.

Authors:  Shun-Ichi Kimura; Jun Odawara; Takatoshi Aoki; Masayuki Yamakura; Masami Takeuchi; Kosei Matsue
Journal:  Int J Hematol       Date:  2009-10-20       Impact factor: 2.490

8.  Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests.

Authors:  Xiaofang Gao; Liangan Chen; Guangrong Hu; Haiyu Mei
Journal:  Ann Saudi Med       Date:  2010 May-Jun       Impact factor: 1.526

9.  Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.

Authors:  Wouter Meersseman; Katrien Lagrou; Johan Maertens; Alexander Wilmer; Greet Hermans; Steven Vanderschueren; Isabel Spriet; Eric Verbeken; Eric Van Wijngaerden
Journal:  Am J Respir Crit Care Med       Date:  2007-09-20       Impact factor: 21.405

Review 10.  Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.

Authors:  P Bulpa; A Dive; Y Sibille
Journal:  Eur Respir J       Date:  2007-10       Impact factor: 16.671

View more
  12 in total

Review 1.  The Role of Diagnostics-Driven Antifungal Stewardship in the Management of Invasive Fungal Infections: A Systematic Literature Review.

Authors:  Arunaloke Chakrabarti; Naglaa Mohamed; Maria Rita Capparella; Andy Townsend; Anita H Sung; Renee Yura; Patricia Muñoz
Journal:  Open Forum Infect Dis       Date:  2022-05-11       Impact factor: 4.423

2.  A 76-year-old man with a right lung adenocarcinoma and invasive Aspergillosis.

Authors:  Vitorino Modesto Dos Santos; Marcos Correa da Trindade; Diogo Wagner da Silva de Souza; Ana Isabel Costa de Menezes; Patricia Midori Oguma; Afonso Lucas Oliveira Nascimento
Journal:  Mycopathologia       Date:  2013-04-25       Impact factor: 2.574

3.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

4.  Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases.

Authors:  Yanan Zhao; Christen R Stensvold; David S Perlin; Maiken C Arendrup
Journal:  J Antimicrob Chemother       Date:  2013-03-05       Impact factor: 5.790

5.  Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.

Authors:  Koen de Heer; Marije G Gerritsen; Caroline E Visser; Mariska Mg Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2019-05-20

6.  Establishment and application of real-time quantitative PCR for diagnosing invasive aspergillosis via the blood in hematological patients: targeting a specific sequence of Aspergillus 28S-ITS2.

Authors:  Yan Li; Li Gao; Yi Ding; Yuanyuan Xu; Minhang Zhou; Wenrong Huang; Yu Jing; Honghua Li; Lili Wang; Li Yu
Journal:  BMC Infect Dis       Date:  2013-06-01       Impact factor: 3.090

7.  Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.

Authors:  Hangyong He; Lin Ding; Bing Sun; Fang Li; Qingyuan Zhan
Journal:  Crit Care       Date:  2012-07-27       Impact factor: 9.097

Review 8.  Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome.

Authors:  Richard C Barton
Journal:  Scientifica (Cairo)       Date:  2013-01-14

9.  Post endodontic Aspergillosis in an immunocompetent individual.

Authors:  Aadithya B Urs; Hanspal Singh; Kalpana Nunia; Sujata Mohanty; Shalini Gupta
Journal:  J Clin Exp Dent       Date:  2015-10-01

Review 10.  Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision.

Authors:  Felix Bongomin; Sara Gago; Rita O Oladele; David W Denning
Journal:  J Fungi (Basel)       Date:  2017-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.